BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11466560)

  • 1. Angiotensin II induces p27(Kip1) expression in renal tubules in vivo: role of reactive oxygen species.
    Wolf G; Wenzel U; Hannken T; Stahl RA
    J Mol Med (Berl); 2001 Jul; 79(7):382-9. PubMed ID: 11466560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II-induced hypertrophy of proximal tubular cells requires p27Kip1.
    Wolf G; Jablonski K; Schroeder R; Reinking R; Shankland SJ; Stahl RA
    Kidney Int; 2003 Jul; 64(1):71-81. PubMed ID: 12787397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive oxygen species stimulate p44/42 mitogen-activated protein kinase and induce p27(Kip1): role in angiotensin II-mediated hypertrophy of proximal tubular cells.
    Hannken T; Schroeder R; Zahner G; Stahl RAK; Wolf G
    J Am Soc Nephrol; 2000 Aug; 11(8):1387-1397. PubMed ID: 10906152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of p27(Kip1) expression by mitogenic and hypertrophic factors: Involvement of transcriptional and posttranscriptional mechanisms.
    Servant MJ; Coulombe P; Turgeon B; Meloche S
    J Cell Biol; 2000 Feb; 148(3):543-56. PubMed ID: 10662779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II-mediated expression of p27Kip1 and induction of cellular hypertrophy in renal tubular cells depend on the generation of oxygen radicals.
    Hannken T; Schroeder R; Stahl RA; Wolf G
    Kidney Int; 1998 Dec; 54(6):1923-33. PubMed ID: 9853257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II regulates the cell cycle of vascular smooth muscle cells from SHR.
    Kubo A; Fukuda N; Teng J; Satoh C; Nakayama M; Kishioka H; Kanmatsuse K
    Am J Hypertens; 2000 Oct; 13(10):1117-24. PubMed ID: 11041167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
    Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
    Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy.
    Braun-Dullaeus RC; Mann MJ; Ziegler A; von der Leyen HE; Dzau VJ
    J Clin Invest; 1999 Sep; 104(6):815-23. PubMed ID: 10491417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of reactive oxygen species in angiotensin II-mediated renal growth, differentiation, and apoptosis.
    Wolf G
    Antioxid Redox Signal; 2005; 7(9-10):1337-45. PubMed ID: 16115039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p27(Kip1) is important in modulating pulmonary artery smooth muscle cell proliferation.
    Fouty BW; Grimison B; Fagan KA; Le Cras TD; Harral JW; Hoedt-Miller M; Sclafani RA; Rodman DM
    Am J Respir Cell Mol Biol; 2001 Nov; 25(5):652-8. PubMed ID: 11713109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori releases a factor(s) inhibiting cell cycle progression of human gastric cell lines by affecting cyclin E/cdk2 kinase activity and Rb protein phosphorylation through enhanced p27(KIP1) protein expression.
    Sommi P; Savio M; Stivala LA; Scotti C; Mignosi P; Prosperi E; Vannini V; Solcia E
    Exp Cell Res; 2002 Nov; 281(1):128-39. PubMed ID: 12441136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of a form of p27(Kip1) not associated with Cdk-cyclin complexes in transforming growth factor-beta-arrested Mv1Lu cells.
    Taipale M; Tiihonen E; Heiskanen A; Laiho M
    Exp Cell Res; 2000 Aug; 259(1):107-16. PubMed ID: 10942583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1).
    Patel V; Lahusen T; Leethanakul C; Igishi T; Kremer M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS; Senderowicz AM
    Clin Cancer Res; 2002 Nov; 8(11):3549-60. PubMed ID: 12429646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of transforming growth factor on cell cycle regulatory molecules in human myeloid leukemia cells.
    Hu X; Zhang X; Zhong Q; Fisher AB; Bryington M; Zuckerman KS
    Oncogene; 2001 Oct; 20(47):6840-50. PubMed ID: 11687963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of cell cycle proteins and prolonged duration of cardiac myocyte hyperplasia in p27KIP1 knockout mice.
    Poolman RA; Li JM; Durand B; Brooks G
    Circ Res; 1999 Jul; 85(2):117-27. PubMed ID: 10417393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells.
    Hsu SL; Hsu JW; Liu MC; Chen LY; Chang CD
    Exp Cell Res; 2000 Aug; 258(2):322-31. PubMed ID: 10896783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel p27(kip1) C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions.
    McAllister SS; Becker-Hapak M; Pintucci G; Pagano M; Dowdy SF
    Mol Cell Biol; 2003 Jan; 23(1):216-28. PubMed ID: 12482975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.
    Shin I; Yakes FM; Rojo F; Shin NY; Bakin AV; Baselga J; Arteaga CL
    Nat Med; 2002 Oct; 8(10):1145-52. PubMed ID: 12244301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAD1 and p27(KIP1) cooperate to promote terminal differentiation of granulocytes and to inhibit Myc expression and cyclin E-CDK2 activity.
    McArthur GA; Foley KP; Fero ML; Walkley CR; Deans AJ; Roberts JM; Eisenman RN
    Mol Cell Biol; 2002 May; 22(9):3014-23. PubMed ID: 11940659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.
    Tanner FC; Boehm M; Akyürek LM; San H; Yang ZY; Tashiro J; Nabel GJ; Nabel EG
    Circulation; 2000 May; 101(17):2022-5. PubMed ID: 10790340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.